封面
市場調查報告書
商品編碼
2162530

抗血栓塗層市場:全球市場預測,2026-2032年

Anti-thrombogenic Coatings Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,抗血栓塗層市場將成長至 19,0473 億美元,複合年成長率為 11.04%。

主要市場統計數據
基準年 2025 9.1496億美元
預計年份:2026年 1,021,010,000 美元
預測年份 2032 190473億美元
複合年成長率 (%) 11.04%

抗血栓塗層:執行摘要

抗血栓塗層旨在抑制與血液接觸的醫療設備表面形成血栓。隨著導管、血管移植物、支架、血液處理系統和其他植入式或介入性療法的應用日益廣泛,抗血栓塗層在醫療保健領域的重要性也日益凸顯。在產品開發過程中,平衡抗血栓性能、生物相容性、耐久性、滅菌兼容性、可製造性和法規核准等因素是決定開發方向的關鍵所在。

臨床的複雜性正在改變塗層的開發方式。

目前的趨勢是從單一功能的表面處理轉向多功能平台,以同時解決血栓症、發炎、感染和機械磨損等問題。開發人員更重視在生理血流下的附著力、長期停留期間的性能、與各種基材的兼容性以及工業規模應用的可重複性。此外,監管要求和臨床預期也要求提供更有力的證據,證明塗層性能、醫療設備性能和患者療效之間的相關性。

人工智慧將加速藥物研發和品管。

人工智慧 (AI) 可透過分析生物材料數據、預測蛋白質吸附、識別有前景的聚合物和藥物組合以及最佳化配方參數,輔助開發抗血栓塗層。它還可用於解讀顯微影像、檢測表面缺陷、製程監控和失效分析。然而,可靠的實施需要具有代表性的資料集、經過實驗檢驗的模型、可追溯的演算法以及管理系統,以確保符合醫療設備的品質和安全要求。

區域性見解:實施取決於臨床基礎設施和法規。

在北美,先進的介入醫學、強大的轉化研究和嚴格的醫療設備監管相結合。在歐洲,生物相容性、生命週期文件以及對不斷變化的醫療設備需求的合規性備受重視。亞太地區受益於不斷擴展的醫療保健體系和成熟的製造生態系統,儘管澳洲、中國、印度、日本和韓國的採用情況各不相同。拉丁美洲受到進口依賴、獲得專科治療機會不均以及各國採購條件差異的影響。中東,特別是海灣國家,正在加大對三級醫療和醫療設備基礎設施的投資,而非洲的情況仍然高度多元化,專科醫療的應用主要集中在資源豐富的都市區和轉診醫療體系中。

集團洞察:貿易集團塑造標準、供應鏈與進入

東協市場環境複雜,醫療設備需求不斷成長,但監管成熟度和生產能力卻存在差異。金磚國家成員國在醫療服務可近性、研發能力和國內生產方面存在顯著差異,這為區域性發展和技術轉移創造了機會。歐盟正在推動監管和科學框架的協調,而七國集團在先進材料研究、臨床實踐和品管系統方面仍發揮著重要作用。海灣合作理事會成員國正在加強其專業醫療基礎設施和採購能力。北約成員國對具有韌性的醫療供應鏈和高度可靠的醫療設備技術有著迫切的需求,但其醫療法規仍以國家或地區為單位,而非在整個聯盟範圍內統一制定。

各國具體情況:各國的能力建設和部署路徑各不相同。

美國和加拿大將先進的醫療設備研究與成熟的介入醫療體系結合。德國、法國、義大利、西班牙和英國在臨床和工程領域擁有強大的實力,但其市場准入受到歐洲和各國自身需求的限制。日本和韓國專注於精密製造、生物材料研究和高品質醫療技術,而中國則不斷提升國內醫療設備研發能力和臨床基礎設施。印度正在發展其醫療體系和國內製造能力。澳洲支持在地域分散的醫療體系內以研究為導向的醫療應用。巴西和墨西哥是拉丁美洲重要的醫療市場,其公共和私人醫療服務水準參差不齊。俄羅斯擁有強大的科學研究和工業實力,但在貿易、採購和監管方面面臨獨特的挑戰。

抗血栓塗層領域領導企業的可行優先事項

行業領導企業應優先考慮具有明確臨床應用案例、可測量作用機制以及在真實血流和無菌條件下獲得的證據的塗層設計。他們還應制定涵蓋材料選擇、表面表徵、製程驗證、毒理學、血液學相容性和長期耐久性的綜合方案。了解區域監管環境並建立健全的採購體系,特別是針對特種聚合物、活性成分和塗層設備,至關重要。與醫院、醫療設備製造商和獨立實驗室建立合作關係可以提高臨床有效性。人工智慧專案應從有限的範圍和可審計的應用開始,並在整個開發和生產過程中保持人工監督。

調查方法:基於證據的市場評估

本執行摘要系統地評估了抗血栓塗層的應用、實行技術、臨床需求、生產製造考量、監管挑戰和地理限制。報告按地區、經濟集團和國家進行分類,區分了普遍存在的行業趨勢和基礎設施、政策及部署方面的區域差異。本分析避免了未經證實的量化論斷,而是專注於檢驗的技術、臨床、營運和監管因素。隨著標準、臨床證據、採購系統和醫療設備技術的不斷發展,報告結果應定期更新。

結論:績效、證據和整合是進步的決定性因素。

抗血栓塗層正日益成為與血液接觸的醫療設備設計中的關鍵要素。其發展取決於將耐用的表面工程與可靠的血液相容性證據、可擴展的生產製造、負責任的人工智慧應用以及符合當地實際情況的監管策略相結合。將材料科學與臨床工作流程、品質系統和供應鏈韌性結合的機構,將更有能力提供更安全、更可靠的醫療設備平台。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章:抗血栓塗層市場:依材料類型分類

  • 肝素
  • 磷酸膽鹼
  • 聚合物
    • 聚乙二醇
    • 兩性離子聚合物
  • 矽酮

第8章:抗血栓塗層市場:依塗層技術分類

  • 浸塗
  • 電漿聚合
    • 常壓電漿
    • 低壓等離子體
  • 自組織
  • 噴塗

第9章:抗血栓塗層市場:依應用領域分類

  • 導管
    • 心血管導管
    • 神經血管導管
  • 心臟瓣膜
    • 機械閥
    • 生物瓣膜
  • 支架
    • 冠狀動脈支架
    • 末梢用支架
  • 血管移植
    • 動脈移植
    • 靜脈移植

第10章:抗血栓塗層市場:依最終用途產業分類

  • 門診手術中心
  • 醫院
  • 研究機構

第11章:抗血栓塗層市場:按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章:抗血栓塗層市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章:抗血栓塗層市場:按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第15章:公司簡介

  • AST Products Inc.
  • Biocoat Inc.
  • Covalon Technologies Ltd.
  • DSM Biomedical
  • Harland Medical Systems Inc.
  • HemCon Medical Technologies Inc.
  • Hemosphere Inc.
  • Hemoteq AG
  • Interface Biologics Inc.
  • Marine Polymer Technologies Inc.
  • MediWhale Inc.
  • MIV Therapeutics Inc.
  • Nanovis Inc.
  • SurModics Inc.

第16章 主要專家

Product Code: MRR-710707546E33

The Anti-thrombogenic Coatings Market is projected to grow by USD 1,904.73 million at a CAGR of 11.04% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 914.96 million
Estimated Year [2026] USD 1,021.01 million
Forecast Year [2032] USD 1,904.73 million
CAGR (%) 11.04%

Anti-Thrombogenic Coatings: Executive Summary

Anti-thrombogenic coatings are engineered to reduce clot formation on blood-contacting medical-device surfaces. Their relevance is increasing as healthcare systems expand the use of catheters, vascular grafts, stents, blood-handling systems, and other implantable or interventional technologies. Product development is shaped by the need to balance thromboresistance, biocompatibility, durability, sterilization compatibility, manufacturability, and regulatory acceptance.

Clinical Complexity Is Reshaping Coating Development

The landscape is shifting from single-function surface treatment toward multifunctional platforms that address thrombosis, inflammation, infection, and mechanical wear together. Developers are placing greater emphasis on adhesion under physiological flow, performance over extended dwell times, compatibility with diverse substrates, and reproducible application at industrial scale. Regulatory and clinical expectations are also encouraging stronger evidence linking coating characteristics to device performance and patient outcomes.

Artificial Intelligence Accelerates Discovery and Quality Control

Artificial intelligence can support anti-thrombogenic-coating development by analyzing biomaterials data, predicting protein adsorption, identifying promising polymer or drug combinations, and optimizing formulation parameters. It can also assist microscopy interpretation, surface-defect detection, process monitoring, and failure analysis. However, reliable deployment depends on representative datasets, experimentally validated models, traceable algorithms, and controls that preserve compliance with medical-device quality and safety requirements.

Regional Insights: Adoption Depends on Clinical Infrastructure and Regulation

North America combines advanced interventional care, strong translational research, and demanding device oversight. Europe emphasizes biocompatibility, lifecycle documentation, and conformity with evolving medical-device requirements. Asia-Pacific benefits from expanding healthcare capacity and sophisticated manufacturing ecosystems, with adoption varying across Australia, China, India, Japan, and South Korea. Latin America is influenced by import dependence, uneven access to specialized procedures, and national procurement conditions. The Middle East is supported by investment in tertiary hospitals and medical-device infrastructure, particularly across the Gulf, while Africa remains highly diverse, with specialized adoption concentrated in better-resourced urban and referral systems.

Group Insights: Trade Blocs Shape Standards, Supply Chains, and Access

ASEAN markets present a mixed environment in which expanding medical-device demand coexists with varied regulatory maturity and manufacturing capabilities. BRICS members reflect substantial differences in healthcare access, research capacity, and domestic production, creating opportunities for localized development and technology transfer. The European Union supports coordinated regulatory and scientific frameworks, while the G7 remains influential in advanced materials research, clinical practice, and quality systems. GCC countries are strengthening specialized healthcare infrastructure and procurement capabilities. NATO members collectively represent important demand for resilient medical supply chains and high-assurance device technologies, although healthcare regulation remains national or regional rather than alliance-wide.

Country Insights: Capabilities and Adoption Follow Distinct National Paths

The United States and Canada combine advanced device research with established interventional-care systems. Germany, France, Italy, Spain, and the United Kingdom have strong clinical and engineering capabilities, with market access shaped by European and national requirements. Japan and South Korea emphasize precision manufacturing, biomaterials research, and high-quality medical technology, while China is expanding domestic device capabilities and clinical infrastructure. India is developing both healthcare capacity and indigenous manufacturing. Australia supports research-led adoption within a geographically dispersed system. Brazil and Mexico are important Latin American healthcare markets with varied public and private access. Russia maintains scientific and industrial capabilities but faces distinct trade, procurement, and regulatory conditions.

Actionable Priorities for Anti-Thrombogenic-Coating Leaders

Industry leaders should prioritize coating designs with clearly defined clinical use cases, measurable mechanisms of action, and evidence generated under realistic blood-flow and sterilization conditions. They should build integrated programs spanning material selection, surface characterization, process validation, toxicology, hemocompatibility, and long-term durability. Regional regulatory mapping and resilient sourcing are essential, particularly for specialized polymers, active agents, and coating equipment. Partnerships with hospitals, device manufacturers, and independent laboratories can improve clinical relevance. AI initiatives should begin with narrowly scoped, auditable applications and maintain human oversight throughout development and production.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses a structured assessment of anti-thrombogenic-coating applications, enabling technologies, clinical requirements, manufacturing considerations, regulatory themes, and geographic conditions. Insights are organized across regional, economic-group, and country dimensions to distinguish broadly observable industry dynamics from local differences in infrastructure, policy, and adoption. The analysis avoids unsupported quantitative claims and emphasizes verifiable technical, clinical, operational, and regulatory factors. Findings should be updated as standards, clinical evidence, procurement systems, and device technologies evolve.

Conclusion: Performance, Evidence, and Integration Will Define Progress

Anti-thrombogenic coatings are becoming an increasingly strategic component of blood-contacting medical-device design. Progress will depend on combining durable surface engineering with robust hemocompatibility evidence, scalable manufacturing, responsible AI use, and regionally appropriate regulatory strategies. Organizations that connect materials science to clinical workflow, quality systems, and supply-chain resilience will be better positioned to deliver safer and more reliable device platforms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Anti-thrombogenic Coatings Market, by Material Type

  • 7.1. Introduction
  • 7.2. Heparin
  • 7.3. Phosphorylcholine
  • 7.4. Polymer
    • 7.4.1. Polyethylene Glycol
    • 7.4.2. Zwitterionic Polymers
  • 7.5. Silicone

8. Anti-thrombogenic Coatings Market, by Coating Technique

  • 8.1. Introduction
  • 8.2. Dip Coating
  • 8.3. Plasma Polymerization
    • 8.3.1. Atmospheric Plasma
    • 8.3.2. Low Pressure Plasma
  • 8.4. Self Assembly
  • 8.5. Spray Coating

9. Anti-thrombogenic Coatings Market, by Application

  • 9.1. Introduction
  • 9.2. Catheters
    • 9.2.1. Cardiovascular Catheters
    • 9.2.2. Neurovascular Catheters
  • 9.3. Heart Valves
    • 9.3.1. Mechanical Valves
    • 9.3.2. Tissue Valves
  • 9.4. Stents
    • 9.4.1. Coronary Stents
    • 9.4.2. Peripheral Stents
  • 9.5. Vascular Grafts
    • 9.5.1. Arterial Grafts
    • 9.5.2. Venous Grafts

10. Anti-thrombogenic Coatings Market, by End-Use Industry

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Anti-thrombogenic Coatings Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Anti-thrombogenic Coatings Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Anti-thrombogenic Coatings Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. AST Products Inc.
  • 15.2. Biocoat Inc.
  • 15.3. Covalon Technologies Ltd.
  • 15.4. DSM Biomedical
  • 15.5. Harland Medical Systems Inc.
  • 15.6. HemCon Medical Technologies Inc.
  • 15.7. Hemosphere Inc.
  • 15.8. Hemoteq AG
  • 15.9. Interface Biologics Inc.
  • 15.10. Marine Polymer Technologies Inc.
  • 15.11. MediWhale Inc.
  • 15.12. MIV Therapeutics Inc.
  • 15.13. Nanovis Inc.
  • 15.14. SurModics Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Anti-thrombogenic Coatings Market, Years Considered for the Study
  • FIGURE 2. Global Anti-thrombogenic Coatings Market, Research Design
  • FIGURE 3. Global Anti-thrombogenic Coatings Market, Research Framework
  • FIGURE 4. Global Anti-thrombogenic Coatings Market, Data Triangulation
  • FIGURE 5. Global Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Anti-thrombogenic Coatings Market Size, by Material Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Anti-thrombogenic Coatings Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Anti-thrombogenic Coatings Market Size, by Coating Technique, 2025 vs 2032 (%)
  • FIGURE 9. Global Anti-thrombogenic Coatings Market Size, by Coating Technique, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Anti-thrombogenic Coatings Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Anti-thrombogenic Coatings Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2025 vs 2032 (%)
  • FIGURE 13. Global Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Anti-thrombogenic Coatings Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Anti-thrombogenic Coatings Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Anti-thrombogenic Coatings Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Anti-thrombogenic Coatings Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Anti-thrombogenic Coatings Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Anti-thrombogenic Coatings Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Anti-thrombogenic Coatings Market Segmentation & Coverage
  • TABLE 2. Global Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 4. Global Heparin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Heparin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Heparin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Phosphorylcholine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Phosphorylcholine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Phosphorylcholine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Polymer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Polymer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Polymer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Polyethylene Glycol Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Polyethylene Glycol Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Polyethylene Glycol Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Zwitterionic Polymers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Zwitterionic Polymers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Zwitterionic Polymers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Silicone Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Silicone Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Silicone Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 23. Global Dip Coating Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Dip Coating Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Dip Coating Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Plasma Polymerization Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Plasma Polymerization Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Plasma Polymerization Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Atmospheric Plasma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Atmospheric Plasma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Atmospheric Plasma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Low Pressure Plasma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Low Pressure Plasma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Low Pressure Plasma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Self Assembly Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Self Assembly Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Self Assembly Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Spray Coating Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Spray Coating Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Spray Coating Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 42. Global Catheters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Catheters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Catheters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Cardiovascular Catheters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Cardiovascular Catheters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Cardiovascular Catheters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Neurovascular Catheters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Neurovascular Catheters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Neurovascular Catheters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Heart Valves Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Heart Valves Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Heart Valves Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Mechanical Valves Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Mechanical Valves Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Mechanical Valves Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Tissue Valves Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Tissue Valves Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Tissue Valves Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Stents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Stents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Stents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Coronary Stents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Peripheral Stents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Peripheral Stents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Peripheral Stents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Vascular Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Vascular Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Vascular Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Arterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Arterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Arterial Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Venous Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Venous Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Venous Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 79. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 91. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 92. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 93. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 94. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 95. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 96. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 97. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 98. Asia-Pacific Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 99. Asia-Pacific Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 100. North America Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. North America Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 102. North America Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 103. North America Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 104. North America Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 105. North America Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 106. North America Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 107. North America Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 108. North America Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 109. North America Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 110. North America Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 111. Latin America Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Latin America Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 113. Latin America Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 114. Latin America Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 115. Latin America Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 116. Latin America Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 117. Latin America Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 118. Latin America Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 119. Latin America Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 120. Latin America Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 121. Latin America Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 122. Europe Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Europe Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 124. Europe Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 125. Europe Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 126. Europe Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 127. Europe Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 128. Europe Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 129. Europe Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 130. Europe Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 131. Europe Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 132. Europe Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 133. Middle East Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Middle East Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 135. Middle East Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 136. Middle East Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 137. Middle East Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 138. Middle East Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 139. Middle East Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 140. Middle East Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 141. Middle East Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 142. Middle East Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 143. Middle East Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 144. Africa Anti-thrombogenic Coatings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 145. Africa Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 146. Africa Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 147. Africa Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 148. Africa Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 149. Africa Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 150. Africa Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 151. Africa Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 152. Africa Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 153. Africa Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 154. Africa Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 155. Global Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 156. ASEAN Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 157. ASEAN Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 158. ASEAN Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 159. ASEAN Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 160. ASEAN Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 161. ASEAN Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 162. ASEAN Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 163. ASEAN Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 164. ASEAN Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 165. ASEAN Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 166. ASEAN Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 167. GCC Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 168. GCC Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 169. GCC Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 170. GCC Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 171. GCC Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 172. GCC Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 173. GCC Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 174. GCC Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 175. GCC Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 176. GCC Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 177. GCC Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 178. European Union Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. European Union Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 180. European Union Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 181. European Union Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 182. European Union Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 183. European Union Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 184. European Union Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 185. European Union Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 186. European Union Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 187. European Union Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 188. European Union Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 189. BRICS Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 190. BRICS Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 191. BRICS Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 192. BRICS Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 193. BRICS Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 194. BRICS Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 195. BRICS Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 196. BRICS Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 197. BRICS Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 198. BRICS Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 199. BRICS Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 200. G7 Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 201. G7 Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 202. G7 Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 203. G7 Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 204. G7 Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 205. G7 Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 206. G7 Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 207. G7 Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 208. G7 Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 209. G7 Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 210. G7 Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 211. NATO Anti-thrombogenic Coatings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 212. NATO Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 213. NATO Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 214. NATO Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 215. NATO Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 216. NATO Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 217. NATO Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 218. NATO Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 219. NATO Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 220. NATO Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 221. NATO Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 222. Global Anti-thrombogenic Coatings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 223. United States Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 224. United States Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 225. United States Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 226. United States Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 227. United States Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 228. United States Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 229. United States Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 230. United States Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 231. United States Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 232. United States Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 233. United States Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 234. Canada Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 235. Canada Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 236. Canada Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 237. Canada Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 238. Canada Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 239. Canada Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 240. Canada Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 241. Canada Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 242. Canada Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 243. Canada Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 244. Canada Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 245. Mexico Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 246. Mexico Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 247. Mexico Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 248. Mexico Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 249. Mexico Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 250. Mexico Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 251. Mexico Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 252. Mexico Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 253. Mexico Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 254. Mexico Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 255. Mexico Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 256. Brazil Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 257. Brazil Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 258. Brazil Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 259. Brazil Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 260. Brazil Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 261. Brazil Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 262. Brazil Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 263. Brazil Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 264. Brazil Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 265. Brazil Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 266. Brazil Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 267. United Kingdom Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 268. United Kingdom Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 269. United Kingdom Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 270. United Kingdom Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 271. United Kingdom Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 272. United Kingdom Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 273. United Kingdom Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 274. United Kingdom Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 275. United Kingdom Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 276. United Kingdom Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 277. United Kingdom Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 278. Germany Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 279. Germany Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 280. Germany Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 281. Germany Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 282. Germany Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 283. Germany Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 284. Germany Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 285. Germany Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 286. Germany Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 287. Germany Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 288. Germany Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 289. France Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 290. France Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 291. France Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 292. France Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 293. France Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 294. France Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 295. France Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 296. France Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 297. France Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 298. France Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 299. France Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 300. Russia Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 301. Russia Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 302. Russia Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 303. Russia Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 304. Russia Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 305. Russia Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 306. Russia Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 307. Russia Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 308. Russia Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 309. Russia Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 310. Russia Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 311. Italy Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 312. Italy Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 313. Italy Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 314. Italy Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 315. Italy Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 316. Italy Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 317. Italy Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 318. Italy Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 319. Italy Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 320. Italy Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 321. Italy Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 322. Spain Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 323. Spain Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 324. Spain Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 325. Spain Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 326. Spain Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 327. Spain Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 328. Spain Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 329. Spain Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 330. Spain Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 331. Spain Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 332. Spain Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 333. China Anti-thrombogenic Coatings Market Size, 2017-2032 (USD Million)
  • TABLE 334. China Anti-thrombogenic Coatings Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 335. China Anti-thrombogenic Coatings Market Size, by Polymer, 2017-2032 (USD Million)
  • TABLE 336. China Anti-thrombogenic Coatings Market Size, by Coating Technique, 2017-2032 (USD Million)
  • TABLE 337. China Anti-thrombogenic Coatings Market Size, by Plasma Polymerization, 2017-2032 (USD Million)
  • TABLE 338. China Anti-thrombogenic Coatings Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 339. China Anti-thrombogenic Coatings Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 340. China Anti-thrombogenic Coatings Market Size, by Heart Valves, 2017-2032 (USD Million)
  • TABLE 341. China Anti-thrombogenic Coatings Market Size, by Stents, 2017-2032 (USD Million)
  • TABLE 342. China Anti-thrombogenic Coatings Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 343. China Anti-thrombogenic Coatings Market Size, by End-Use Industry, 2017-2032 (USD Million)
  • TABLE 344. India Anti-thrombogenic Coatings Market Size